{
    "paper_id": "3d3585b82ae489d1d842feb92426b5bca400a026",
    "metadata": {
        "title": "Acknowledgement to Referees",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The COVID-19 pandemic has continued to present many challenges and I would like to thank all who have contributed to ensuring the journal has thrived despite the ongoing issues.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "I would like to start by thanking the authors of the articles published in Clinical Drug Investigation over the course of 2021. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The quality of published articles is also testament to the diligence of the peer reviewers. I would like to acknowledge the following individuals who acted as reviewers for Clinical Drug Investigation in the last 12 months: ",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "The cost-effectiveness of a COVID-19 vaccine in a Danish context",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Debrabant",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Gr\u00f8nbaekl",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Kronborg",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Clin Drug Investig",
            "volume": "41",
            "issn": "",
            "pages": "975--988",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-021-01085-8"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Acetylsalicylic acid compared with enoxaparin for the prevention of thrombosis and mechanical ventilation in COVID-19 patients: a retrospective cohort study",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "W"
                    ],
                    "last": "Abdelwahab",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Shaltout",
                    "suffix": ""
                },
                {
                    "first": "Sayed",
                    "middle": [],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "A"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Clin Drug Investig",
            "volume": "41",
            "issn": "",
            "pages": "723--732",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-021-01061-2"
                ]
            }
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Can mRNA vaccines turn the tables during the COVID-19 pandemic? Current status and challenges",
            "authors": [
                {
                    "first": "Sagili",
                    "middle": [],
                    "last": "Anthony",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Sivakumar",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Venugopal",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Clin Drug Investig",
            "volume": "41",
            "issn": "",
            "pages": "499--509",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-021-01022-9"
                ]
            }
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Observational study of chlorpromazine in hospitalized patients with COVID-19",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hoertel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "S\u00e1nchez-Rico",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Vernet",
                    "suffix": ""
                }
            ],
            "year": 2021,
            "venue": "Clin Drug Investig",
            "volume": "41",
            "issn": "",
            "pages": "221--233",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-021-01001-0"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Could tocilizumab be an attractive therapeutic option for elderly patients with severe COVID-19? A case report",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Streicher",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Engalenc",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gaudin",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Drug Investig",
            "volume": "40",
            "issn": "",
            "pages": "1085--1088",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-020-00969-5"
                ]
            }
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Proton pump inhibitors are risk factors for viral infections: even for COVID-19?",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Charpiat",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bleyzac",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tod",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Drug Investig",
            "volume": "40",
            "issn": "",
            "pages": "897--899",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-020-00963-x"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Azithromycin for COVID-19: more than just an antimicrobial?",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bleyzac",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Goutelle",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bourguignon",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Drug Investig",
            "volume": "40",
            "issn": "",
            "pages": "683--686",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-020-00933-3"
                ]
            }
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "An updated systematic review of the therapeutic role of hydroxychloroquine in coronavirus disease-19 (COVID-19)",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Das",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bhowmick",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tiwari",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Drug Investig",
            "volume": "40",
            "issn": "",
            "pages": "591--601",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-020-00927-1"
                ]
            }
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Rational use of tocilizumab in the treatment of novel coronavirus pneumonia",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Drug Investig",
            "volume": "40",
            "issn": "",
            "pages": "511--518",
            "other_ids": {
                "DOI": [
                    "10.1007/s40261-020-00917-3"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Sustainable Development Goals (SDG) Programme' is aiming to connect researchers who are tackling the world's toughest challenges with practitioners in policy and business, while the 'Women in Science' initiative aims to help empower more women scientists to achieve scientific excellence. Finally, I am delighted to inform you that Springer Nature is now carbon neutral for its direct operations (offices, fleet and flights) and earlier this year signed The Climate Pledge",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Returning to Clinical Drug Investigation, the editorial program for 2022 is well under way, and I am looking forward to bringing you many high-quality and authoritative articles over the coming year",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Switzerland Robert J. Kreitman, USA Akira Kuriyama, Japan Valentina Leta, UK Theresa Leung, Hong Kong, China Peter A. Lio, USA David M. Mannino, USA Louise-Laure Mariani, France Paolo Martelletti, Italy Ann McCormack, Australia Andrea Melani, Italy Cristiane A. Menezes de Padua, Brazil Gideon Meyerowitz-Katz, Australia",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}